Princeton Capital Management Inc’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$473K Buy
7,748
+1,467
+23% +$88.9K 0.24% 55
2017
Q2
$384K Hold
6,281
0.24% 55
2017
Q1
$381K Hold
6,281
0.24% 53
2016
Q4
$353K Hold
6,281
0.24% 56
2016
Q3
$374K Sell
6,281
-419
-6% -$24.5K 0.24% 62
2016
Q2
$368K Buy
6,700
+613
+10% +$32.6K 0.25% 60
2016
Q1
$307K Buy
6,087
+1,555
+34% +$76.2K 0.21% 57
2015
Q4
$228K Buy
+4,532
New +$228K 0.16% 59
2015
Q3
Sell
-62,370
Closed -$3.39M 69
2015
Q2
$3.39M Buy
62,370
+215
+0.3% +$12.1K 1.79% 27
2015
Q1
$3.41M Buy
62,155
+7,520
+14% +$426K 1.75% 28
2014
Q4
$2.96M Buy
54,635
+8,001
+17% +$446K 1.64% 29
2014
Q3
$2.64M Buy
46,634
+9,600
+26% +$539K 1.68% 28
2014
Q2
$2.04M Buy
+37,034
New +$2.02M 1.41% 31

Other funds holding MRK

Princeton Capital Management Inc's MRK Position: Q3 2017 in Review

Princeton Capital Management Inc increased its Merck (MRK) stake by 23% in Q3 2017, buying an estimated $88.9K and bringing the position to 7,748 shares worth $473K. The position accounts for 0.24% of the portfolio, ranked #55.

Princeton Capital Management Inc first reported a position in MRK in Q2 2014 and has held it in 13 quarters since. The position peaked at $3.41M in Q1 2015. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Princeton Capital Management Inc held 7,748 shares of Merck worth $473K as of Q3 2017.
  • Princeton Capital Management Inc bought 1,467 Merck shares in Q3 2017, an estimated $88.9K.
  • Merck made up 0.24% of Princeton Capital Management Inc's portfolio in Q3 2017, its #55 holding.
  • Princeton Capital Management Inc first reported a position in Merck in Q2 2014 and has held it in 13 quarters since.
  • Princeton Capital Management Inc's Merck position peaked at $3.41M in Q1 2015.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.